Literature DB >> 17035926

Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation--United States, 2003-2005.

.   

Abstract

Arthritis is highly prevalent among U.S. adults, the leading cause of disability, and associated with substantial activity limitation, work disability, reduced quality of life, and high health-care costs. As the population ages, arthritis is expected to affect an estimated 67 million adults in the United States by 2030. This report updates estimates of the national prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation in the adult U.S. population, using data from the National Health Interview Survey (NHIS) for 2003-2005. The findings indicated that an estimated 21.6% of the adult U.S. population (46.4 million persons) had doctor-diagnosed arthritis, and 8.3% (17.4 million) had arthritis-attributable activity limitations. Public and private health agencies should promote measures to increase the availability of evidence-based arthritis prevention and management interventions.

Entities:  

Mesh:

Year:  2006        PMID: 17035926

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  44 in total

Review 1.  Evidence-based knee injections for the management of arthritis.

Authors:  Olivia T Cheng; Dmitri Souzdalnitski; Bruce Vrooman; Jianguo Cheng
Journal:  Pain Med       Date:  2012-05-23       Impact factor: 3.750

2.  Repair of cartilage defects in arthritic tissue with differentiated human embryonic stem cells.

Authors:  Tsaiwei Olee; Shawn P Grogan; Martin K Lotz; Clifford W Colwell; Darryl D D'Lima; Evan Y Snyder
Journal:  Tissue Eng Part A       Date:  2013-10-19       Impact factor: 3.845

3.  The state of the science in the prevention and management of osteoarthritis: experts recommend ways to increase nurses' awareness and knowledge of osteoarthritis.

Authors:  Laura Robbins; Marjorie G Kulesa
Journal:  HSS J       Date:  2012-07

4.  Enhanced therapeutic anti-inflammatory effect of betamethasone on topical administration with low-frequency, low-intensity (20 kHz, 100 mW/cm(2)) ultrasound exposure on carrageenan-induced arthritis in a mouse model.

Authors:  Gadi Cohen; Hiba Natsheh; Youhan Sunny; Christopher R Bawiec; Elka Touitou; Melissa A Lerman; Philip Lazarovici; Peter A Lewin
Journal:  Ultrasound Med Biol       Date:  2015-05-21       Impact factor: 2.998

5.  Clinical trials in rheumatoid arthritis: a status report from the ClinicalTrials.gov website.

Authors:  Jisna R Paul; Prabha Ranganathan
Journal:  Rheumatol Int       Date:  2011-07-19       Impact factor: 2.631

6.  A comparison of the arthritis foundation self-help program across three race/ethnicity groups.

Authors:  Samantha J Parker; Romulo Vasquez; Emily K Chen; Charles R Henderson; Karl Pillemer; Laura Robbins; M C Reid
Journal:  Ethn Dis       Date:  2011       Impact factor: 1.847

7.  Hierarchically designed agarose and poly(ethylene glycol) interpenetrating network hydrogels for cartilage tissue engineering.

Authors:  Brandon J DeKosky; Nathan H Dormer; Ganesh C Ingavle; Christopher H Roatch; Joseph Lomakin; Michael S Detamore; Stevin H Gehrke
Journal:  Tissue Eng Part C Methods       Date:  2010-07-13       Impact factor: 3.056

8.  Arthritis prevalence and associations in American Indian and Alaska Native people.

Authors:  Elizabeth D Ferucci; M Catherine Schumacher; Anne P Lanier; Maureen A Murtaugh; Sandra Edwards; Laurie J Helzer; Lillian Tom-Orme; Martha L Slattery
Journal:  Arthritis Rheum       Date:  2008-08-15

9.  Relationships between the built environment and walking and weight status among older women in three U.S. States.

Authors:  Philip J Troped; Heather A Starnes; Robin C Puett; Kosuke Tamura; Ellen K Cromley; Peter James; Eran Ben-Joseph; Steven J Melly; Francine Laden
Journal:  J Aging Phys Act       Date:  2013-03-26       Impact factor: 1.961

10.  The prevalence and functional impact of musculoskeletal conditions amongst clients of a primary health care facility in an under-resourced area of Cape Town.

Authors:  Romy Parker; Jennifer Jelsma
Journal:  BMC Musculoskelet Disord       Date:  2010-01-04       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.